HUTCHMED (China) Ltd
HCM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001648257
No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.
Other share classesHMDCF
Q3 2021 vs. Q2 2021
How the institutions holding HUTCHMED (China) Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 146 | 3 | 145 | +2 |
| Shares | 46.5M | 118.1K | 54.0M | +7.67M (+16.5%) |
| Value | $1.81B | $1.50M | $1.89B | +$74.1M (+4.1%) |
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held HUTCHMED (China) Ltd at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| General Atlantic LLC | 4,000,000 | $146.4M | 0.86% |
| Capital Group Private Client Services, Inc. | 248,531 | $9.10M | 0.11% |
| Pictet Asset Management SA | 115,400 | $843.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 12,652 | $463.0K | 0.00% |
| Andra AP-fonden | 5,600 | $205.0K | 0.00% |
| KBC Group NV | 5,135 | $188.0K | 0.00% |
| Macquarie Group Ltd | 4,454 | $163.0K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 478 | $17.0K | 0.00% |
| Segantii Capital Management Ltd | 100 | $4.00K | 0.00% |
| Captrust Financial Advisors | 78 | $3.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 45 | $2.00K | 0.00% |
| AdvisorNet Financial, Inc | 42 | $2.00K | 0.00% |
| BerganKDV Wealth Management, LLC | 68 | $2.00K | 0.00% |
| SRS Capital Advisors, Inc. | 15 | $1.00K | 0.00% |
| NEXT Financial Group, Inc | 40 | $1.00K | 0.00% |
| Glassman Wealth Services | 7 | $0 | 0.00% |
| Meridian Wealth Partners, LLC | 7 | $0 | 0.00% |
Sold out (15)
Institutions that held HUTCHMED (China) Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Capital Bank & Trust Co | 260,253 | $10.2M |
| Pinz Capital Management, LP | 159,400 | $6.26M |
| HRT Financial LP | 68,536 | $2.69M |
| Jane Street Group, LLC | 43,117 | $1.69M |
| Marshall Wace Asia Ltd | 33,243 | $1.30M |
| Tiger Pacific Capital LP | 27,532 | $1.08M |
| Squarepoint Ops LLC | 20,908 | $821.0K |
| Virtu Financial LLC | 20,841 | $818.0K |
| Susquehanna International Group, LLP | 17,331 | $681.0K |
| Comerica Bank | 9,435 | $362.0K |
| Campbell & CO Investment Adviser LLC | 6,400 | $251.0K |
| Lazard Asset Management LLC | 5,073 | $199.0K |
| Eaton Vance Management | 500 | $20.0K |
| Cutler Group LP | 100 | $3.00K |
| Manchester Capital Management LLC | 49 | $2.00K |
Not filed for Q3 2021 yet (3)
Institutions that held HUTCHMED (China) Ltd at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 99,500 | $767.0K |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730.0K |
| CWM, LLC | 21 | $1.00K |